京新药业向香港联交所递交境外上市股份（H股）发行上市申请并刊发申请资料

Core Viewpoint - Jingxin Pharmaceutical (002020) has submitted an application for the issuance of overseas listed shares (H shares) and for listing on the main board of the Hong Kong Stock Exchange [1] Group 1 - The application was submitted on February 11 and the related documents were published on the Hong Kong Stock Exchange website on the same day [1]